In the last 12 months, insiders at Serina Therapeutics, Inc. ($SER) filed 185 transactions with the SEC: 30 open-market purchases totaling $794,226 and 41 sales totaling $1,119,714. Net insider sentiment: net selling.
Serina Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Juvenescence Ltd (TenPercentOwner) — 8 transactions totaling $14,987,818
- Bailey Gregory (Director) — 19 transactions totaling $4,454,756
- Moreadith Randall (Chief Scientific Officer) — 124 transactions totaling $1,134,924
- Venkatesan Jay (Director) — 3 transactions totaling $500,000
- MINTZ STEVEN (Director) — 15 transactions totaling $289,469
View all SEC Filings for Serina Therapeutics, Inc. (SER).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 23, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| March 23, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $2.86 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| March 23, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 267,686.0000 | 10,339,000 | 2.37% | 0.06% |
| March 19, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 39000 | $0.06 | 39,000.0000 | 10,339,000 | 9999.99% | 0.38% |
| March 19, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 39000 | $0.00 | 274,186.0000 | 10,339,000 | 12.45% | 0.38% |
| March 19, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 39000 | $2.50 | 0.0000 | 10,339,000 | 100.00% | 0.38% |
| Feb. 3, 2026 | GILL SIMBA | Director | A | Stock Option (right to buy) | 92000 | $0.00 | 92,000.0000 | 10,339,000 | 9999.99% | 0.89% |
| Feb. 3, 2026 | LEDGER STEVEN A | Chief Executive Officer | A | Stock Option (right to buy) | 230100 | $0.00 | 230,100.0000 | 10,339,000 | 9999.99% | 2.23% |
| Feb. 3, 2026 | Tenjarla Srini | SVP, CMC & Formulation | A | Stock Option (right to buy) | 69000 | $0.00 | 69,000.0000 | 10,339,000 | 9999.99% | 0.67% |
| Feb. 3, 2026 | Moreadith Randall | Chief Scientific Officer | A | Stock Option (right to buy) | 69000 | $0.00 | 69,000.0000 | 10,339,000 | 9999.99% | 0.67% |
| Feb. 2, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $3.03 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Feb. 2, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Feb. 2, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 313,186.0000 | 10,339,000 | 2.03% | 0.06% |
| Jan. 28, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Jan. 28, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 319,686.0000 | 10,339,000 | 1.99% | 0.06% |
| Jan. 28, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $3.57 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Jan. 22, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2500 | $0.06 | 2,500.0000 | 10,339,000 | 9999.99% | 0.02% |
| Jan. 22, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2500 | $0.00 | 326,186.0000 | 10,339,000 | 0.76% | 0.02% |
| Jan. 22, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2500 | $2.95 | 0.0000 | 10,339,000 | 100.00% | 0.02% |
| Jan. 20, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2000 | $0.06 | 2,000.0000 | 10,339,000 | 9999.99% | 0.02% |
| Jan. 21, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2000 | $0.00 | 328,686.0000 | 10,339,000 | 0.60% | 0.02% |
| Jan. 21, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2000 | $3.00 | 0.0000 | 10,339,000 | 100.00% | 0.02% |
| Jan. 20, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2000 | $0.00 | 330,686.0000 | 10,339,000 | 0.60% | 0.02% |
| Jan. 21, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2000 | $0.06 | 2,000.0000 | 10,339,000 | 9999.99% | 0.02% |
| Jan. 20, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2000 | $3.07 | 0.0000 | 10,339,000 | 100.00% | 0.02% |
| Jan. 13, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5416 | $0.06 | 5,416.0000 | 10,339,000 | 9999.99% | 0.05% |
| Jan. 14, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 1084 | $0.00 | 332,686.0000 | 10,339,000 | 0.32% | 0.01% |
| Jan. 13, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5416 | $0.00 | 333,770.0000 | 10,339,000 | 1.60% | 0.05% |
| Jan. 14, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 1084 | $2.50 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Jan. 14, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 1084 | $0.06 | 1,084.0000 | 10,339,000 | 9999.99% | 0.01% |
| Jan. 13, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5416 | $2.50 | 0.0000 | 10,339,000 | 100.00% | 0.05% |
| Jan. 8, 2026 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 13000 | $0.00 | 339,186.0000 | 10,339,000 | 3.69% | 0.13% |
| Jan. 8, 2026 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 13000 | $0.06 | 13,000.0000 | 10,339,000 | 9999.99% | 0.13% |
| Jan. 8, 2026 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 13000 | $2.69 | 0.0000 | 10,339,000 | 100.00% | 0.13% |
| Dec. 23, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 4100 | $2.60 | 0.0000 | 10,339,000 | 100.00% | 0.04% |
| Dec. 23, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 4100 | $0.00 | 352,186.0000 | 10,339,000 | 1.15% | 0.04% |
| Dec. 23, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 4100 | $0.06 | 4,100.0000 | 10,339,000 | 9999.99% | 0.04% |
| Dec. 22, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5673 | $0.00 | 356,286.0000 | 10,339,000 | 1.57% | 0.05% |
| Dec. 22, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5673 | $0.06 | 5,673.0000 | 10,339,000 | 9999.99% | 0.05% |
| Dec. 22, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5673 | $2.67 | 0.0000 | 10,339,000 | 100.00% | 0.05% |
| Dec. 16, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 3227 | $0.00 | 361,959.0000 | 10,339,000 | 0.88% | 0.03% |
| Dec. 16, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 3227 | $2.96 | 0.0000 | 10,339,000 | 100.00% | 0.03% |
| Dec. 16, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 3227 | $0.06 | 3,227.0000 | 10,339,000 | 9999.99% | 0.03% |
| Dec. 12, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 1700 | $3.26 | 0.0000 | 10,339,000 | 100.00% | 0.02% |
| Dec. 12, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 1700 | $0.06 | 1,700.0000 | 10,339,000 | 9999.99% | 0.02% |
| Dec. 12, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 1700 | $0.00 | 365,186.0000 | 10,339,000 | 0.46% | 0.02% |
| Dec. 11, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 3555 | $0.06 | 3,555.0000 | 10,339,000 | 9999.99% | 0.03% |
| Dec. 11, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 3555 | $0.00 | 366,886.0000 | 10,339,000 | 0.96% | 0.03% |
| Dec. 11, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 3555 | $3.24 | 0.0000 | 10,339,000 | 100.00% | 0.03% |
| Dec. 10, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 645 | $0.00 | 370,441.0000 | 10,339,000 | 0.17% | 0.01% |
| Dec. 10, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 645 | $3.35 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Dec. 10, 2025 | Moreadith Randall | Chief Scientific Officer | A | Common Stock | 645 | $0.06 | 645.0000 | 10,339,000 | 9999.99% | 0.01% |
| Dec. 9, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 600 | $3.31 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Dec. 9, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 600 | $0.06 | 600.0000 | 10,339,000 | 9999.99% | 0.01% |
| Dec. 9, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 600 | $0.00 | 371,086.0000 | 10,339,000 | 0.16% | 0.01% |
| Dec. 2, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 1500 | $0.06 | 1,500.0000 | 10,339,000 | 9999.99% | 0.01% |
| Dec. 3, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5000 | $0.06 | 5,000.0000 | 10,339,000 | 9999.99% | 0.05% |
| Dec. 3, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5000 | $3.52 | 0.0000 | 10,339,000 | 100.00% | 0.05% |
| Dec. 2, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 1500 | $0.00 | 376,686.0000 | 10,339,000 | 0.40% | 0.01% |
| Dec. 3, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5000 | $0.00 | 371,686.0000 | 10,339,000 | 1.33% | 0.05% |
| Dec. 2, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 1500 | $3.91 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Nov. 25, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5965 | $0.06 | 11,930.0000 | 10,339,000 | 100.00% | 0.06% |
| Nov. 25, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5965 | $0.00 | 378,186.0000 | 10,339,000 | 1.55% | 0.06% |
| Nov. 25, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5965 | $3.90 | 5,965.0000 | 10,339,000 | 50.00% | 0.06% |
| Nov. 24, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 535 | $0.06 | 535.0000 | 10,339,000 | 9999.99% | 0.01% |
| Nov. 24, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 535 | $0.00 | 384,151.0000 | 10,339,000 | 0.14% | 0.01% |
| Nov. 24, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 535 | $3.94 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Nov. 18, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 384,686.0000 | 10,339,000 | 1.66% | 0.06% |
| Nov. 18, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $3.75 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Nov. 18, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Nov. 10, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 391,186.0000 | 10,339,000 | 1.63% | 0.06% |
| Nov. 10, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $4.10 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Nov. 10, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Nov. 7, 2025 | Marshall Richard Peter | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 10,339,000 | 9999.99% | 0.10% |
| Nov. 7, 2025 | Bailey Gregory | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 10,339,000 | 9999.99% | 0.10% |
| Nov. 7, 2025 | Brannan Stephen K. | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 10,339,000 | 9999.99% | 0.10% |
| Nov. 7, 2025 | Venkatesan Jay | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 10,339,000 | 9999.99% | 0.10% |
| Nov. 7, 2025 | WILSON KAREN J | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 10,339,000 | 9999.99% | 0.10% |
| Nov. 5, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 3398 | $0.06 | 3,398.0000 | 10,339,000 | 9999.99% | 0.03% |
| Nov. 5, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 3398 | $0.00 | 397,686.0000 | 10,339,000 | 0.85% | 0.03% |
| Nov. 5, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 3398 | $4.24 | 0.0000 | 10,339,000 | 100.00% | 0.03% |
| Nov. 4, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 3102 | $0.06 | 3,102.0000 | 10,339,000 | 9999.99% | 0.03% |
| Nov. 4, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 3102 | $0.00 | 401,084.0000 | 10,339,000 | 0.77% | 0.03% |
| Nov. 4, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 3102 | $4.40 | 0.0000 | 10,339,000 | 100.00% | 0.03% |
| Oct. 28, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5551 | $0.00 | 404,186.0000 | 10,339,000 | 1.35% | 0.05% |
| Oct. 28, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5551 | $4.96 | 0.0000 | 10,339,000 | 100.00% | 0.05% |
| Oct. 28, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5551 | $0.06 | 5,551.0000 | 10,339,000 | 9999.99% | 0.05% |
| Oct. 27, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 949 | $0.06 | 949.0000 | 10,339,000 | 9999.99% | 0.01% |
| Oct. 27, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 949 | $0.00 | 409,737.0000 | 10,339,000 | 0.23% | 0.01% |
| Oct. 27, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 949 | $5.19 | 0.0000 | 10,339,000 | 100.00% | 0.01% |
| Oct. 20, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 410,686.0000 | 10,339,000 | 1.56% | 0.06% |
| Oct. 20, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 10,339,000 | 9999.99% | 0.06% |
| Oct. 20, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $4.97 | 0.0000 | 10,339,000 | 100.00% | 0.06% |
| Oct. 13, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 4326 | $0.06 | 4,326.0000 | 10,339,000 | 9999.99% | 0.04% |
| Oct. 13, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 4326 | $5.20 | 0.0000 | 10,339,000 | 100.00% | 0.04% |
| Oct. 13, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 4326 | $0.00 | 417,186.0000 | 10,339,000 | 1.03% | 0.04% |
| Aug. 26, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 45632 | $0.00 | 421,512.0000 | 7,359,000 | 9.77% | 0.62% |
| Aug. 25, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2042 | $0.00 | 467,144.0000 | 7,359,000 | 0.44% | 0.03% |
| Aug. 26, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 45632 | $7.01 | 0.0000 | 7,359,000 | 100.00% | 0.62% |
| Aug. 25, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2042 | $5.65 | 0.0000 | 7,359,000 | 100.00% | 0.03% |
| Aug. 26, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 45632 | $0.06 | 45,632.0000 | 7,359,000 | 9999.99% | 0.62% |
| Aug. 25, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2042 | $0.06 | 2,042.0000 | 7,359,000 | 9999.99% | 0.03% |
| Aug. 20, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2077 | $0.00 | 469,186.0000 | 7,359,000 | 0.44% | 0.03% |
| Aug. 18, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2227 | $0.06 | 2,227.0000 | 7,359,000 | 9999.99% | 0.03% |
| Aug. 18, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2227 | $5.25 | 0.0000 | 7,359,000 | 100.00% | 0.03% |
| Aug. 20, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 2077 | $0.06 | 2,077.0000 | 7,359,000 | 9999.99% | 0.03% |
| Aug. 20, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 2077 | $5.10 | 0.0000 | 7,359,000 | 100.00% | 0.03% |
| Aug. 18, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 2227 | $0.00 | 471,263.0000 | 7,359,000 | 0.47% | 0.03% |
| Aug. 12, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5500 | $0.06 | 5,500.0000 | 7,359,000 | 9999.99% | 0.07% |
| Aug. 12, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5500 | $5.25 | 0.0000 | 7,359,000 | 100.00% | 0.07% |
| Aug. 12, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5500 | $0.00 | 473,490.0000 | 7,359,000 | 1.15% | 0.07% |
| Aug. 4, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 5500 | $0.06 | 5,500.0000 | 7,359,000 | 9999.99% | 0.07% |
| Aug. 4, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 5500 | $5.17 | 0.0000 | 7,359,000 | 100.00% | 0.07% |
| Aug. 4, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 5500 | $0.00 | 478,990.0000 | 7,359,000 | 1.14% | 0.07% |
| July 29, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 4196 | $0.06 | 4,196.0000 | 7,359,000 | 9999.99% | 0.06% |
| July 29, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 4196 | $6.50 | 0.0000 | 7,359,000 | 100.00% | 0.06% |
| July 29, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 4196 | $0.00 | 484,490.0000 | 7,359,000 | 0.86% | 0.06% |
| July 28, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| July 28, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.89 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| July 28, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 488,686.0000 | 7,359,000 | 1.31% | 0.09% |
| July 21, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.34 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| July 21, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| July 21, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 495,186.0000 | 7,359,000 | 1.30% | 0.09% |
| July 14, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| July 14, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.01 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| July 14, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 501,686.0000 | 7,359,000 | 1.28% | 0.09% |
| July 7, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| July 7, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.67 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| July 7, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 508,186.0000 | 7,359,000 | 1.26% | 0.09% |
| June 30, 2025 | Moreadith Randall | Chief Scientific Officer | M | Common Stock | 6500 | $0.06 | 6,500.0000 | 7,359,000 | 9999.99% | 0.09% |
| June 30, 2025 | Moreadith Randall | Chief Scientific Officer | S | Common Stock | 6500 | $5.78 | 0.0000 | 7,359,000 | 100.00% | 0.09% |
| June 30, 2025 | Moreadith Randall | Chief Scientific Officer | M | Stock Option (right to buy) | 6500 | $0.00 | 514,686.0000 | 7,359,000 | 1.25% | 0.09% |
| May 22, 2025 | Brannan Stephen K. | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 7,359,000 | 9999.99% | 0.54% |
| April 8, 2025 | Venkatesan Jay | Director | A | Series A Convertible Preferred Stock | 96525 | $5.18 | 96,525.0000 | 7,359,000 | 9999.99% | 1.31% |
| April 8, 2025 | Bailey Gregory | Director | A | Series A Convertible Preferred Stock | 762548 | $5.18 | 762,548.0000 | 7,359,000 | 9999.99% | 10.36% |
| March 28, 2025 | LEDGER STEVEN A | Chief Executive Officer | J | Common Stock | 95730 | $0.00 | 95,730.0000 | 7,359,000 | 9999.99% | 1.30% |
| Feb. 12, 2025 | Venkatesan Jay | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 7,359,000 | 9999.99% | 0.54% |
| June 6, 2024 | Juvenescence Ltd | TenPercentOwner | M | Common Stock | 377865 | $13.20 | 5,534,376.0000 | 7,351,000 | 7.33% | 5.14% |
| Nov. 27, 2024 | Juvenescence Ltd | TenPercentOwner | A | Common Stock | 500000 | $10.00 | 6,034,376.0000 | 10,751,000 | 9.03% | 4.65% |
| Jan. 31, 2025 | Juvenescence Ltd | TenPercentOwner | A | Common Stock | 500000 | $10.00 | 6,034,376.0000 | 7,359,000 | 9.03% | 6.79% |
| June 6, 2024 | Juvenescence Ltd | TenPercentOwner | M | Warrants | 377865 | $0.00 | 755,728.0000 | 7,351,000 | 33.33% | 5.14% |
| June 6, 2024 | Juvenescence Ltd | TenPercentOwner | A | Warrants | 377865 | $0.00 | 377,865.0000 | 7,351,000 | 9999.99% | 5.14% |
| Nov. 27, 2024 | Juvenescence Ltd | TenPercentOwner | A | Warrants | 377864 | $0.00 | 377,864.0000 | 10,751,000 | 9999.99% | 3.51% |
| Nov. 27, 2024 | Juvenescence Ltd | TenPercentOwner | D | Warrants | 755728 | $0.00 | 0.0000 | 10,751,000 | 100.00% | 7.03% |
| Jan. 31, 2025 | Juvenescence Ltd | TenPercentOwner | A | Warrants | 377864 | $0.00 | 755,728.0000 | 7,359,000 | 100.00% | 5.13% |
| Jan. 14, 2025 | WILSON KAREN J | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 7,359,000 | 9999.99% | 0.54% |
| Dec. 17, 2024 | Bailey Gregory | Director | P | Common Stock | 3866 | $4.59 | 67,243.0000 | 10,751,000 | 6.10% | 0.04% |
| Sept. 20, 2024 | Bailey Gregory | Director | P | Common Stock | 1137 | $6.03 | 63,377.0000 | 7,351,000 | 1.83% | 0.02% |
| Sept. 18, 2024 | Bailey Gregory | Director | P | Common Stock | 2709 | $6.23 | 50,561.0000 | 7,351,000 | 5.66% | 0.04% |
| Sept. 19, 2024 | Bailey Gregory | Director | P | Common Stock | 11679 | $6.11 | 62,240.0000 | 7,351,000 | 23.10% | 0.16% |
| Sept. 12, 2024 | MINTZ STEVEN | Director | P | Common Stock | 6000 | $6.47 | 38,230.0000 | 7,351,000 | 18.62% | 0.08% |
| Sept. 9, 2024 | LEDGER STEVEN A | Chief Executive Officer | A | Stock Option (right to buy) | 376388 | $0.00 | 490,350.0000 | 7,351,000 | 330.28% | 5.12% |
| Aug. 20, 2024 | Bailey Gregory | Director | P | Common Stock | 1776 | $8.25 | 47,582.0000 | 7,351,000 | 3.88% | 0.02% |
| Aug. 15, 2024 | CURHAN GREGORY S | Chief Financial Officer | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 7,351,000 | 9999.99% | 3.40% |
| Aug. 15, 2024 | Bailey Gregory | Director | P | Common Stock | 6400 | $6.65 | 33,006.0000 | 7,351,000 | 24.05% | 0.09% |
| Aug. 16, 2024 | Bailey Gregory | Director | P | Common Stock | 6400 | $7.31 | 39,406.0000 | 7,351,000 | 19.39% | 0.09% |
| Aug. 19, 2024 | Bailey Gregory | Director | P | Common Stock | 6400 | $7.93 | 45,806.0000 | 7,351,000 | 16.24% | 0.09% |
| Aug. 15, 2024 | MINTZ STEVEN | Director | P | Common Stock | 1350 | $6.59 | 32,230.0000 | 7,351,000 | 4.37% | 0.02% |
| Aug. 15, 2024 | MINTZ STEVEN | Director | P | Common Stock | 1543 | $6.59 | 32,230.0000 | 7,351,000 | 5.03% | 0.02% |
| Aug. 15, 2024 | MINTZ STEVEN | Director | P | Common Stock | 1800 | $6.59 | 32,230.0000 | 7,351,000 | 5.92% | 0.02% |
| Aug. 15, 2024 | MINTZ STEVEN | Director | P | Common Stock | 1600 | $6.59 | 32,230.0000 | 7,351,000 | 5.22% | 0.02% |
| Aug. 15, 2024 | MINTZ STEVEN | Director | P | Common Stock | 2650 | $6.59 | 32,230.0000 | 7,351,000 | 8.96% | 0.04% |
| Aug. 14, 2024 | Bailey Gregory | Director | P | Common Stock | 6400 | $7.07 | 26,606.0000 | 7,351,000 | 31.67% | 0.09% |
| July 15, 2024 | Tenjarla Srini | SVP, CMC & Formulation | A | Stock Option (right to buy) | 185000 | $0.00 | 185,000.0000 | 7,351,000 | 9999.99% | 2.52% |
| June 21, 2024 | MINTZ STEVEN | Director | P | Common Stock | 5000 | $9.50 | 20,687.0000 | 7,351,000 | 31.87% | 0.07% |
| June 25, 2024 | MINTZ STEVEN | Director | P | Common Stock | 2600 | $9.00 | 23,287.0000 | 7,351,000 | 12.57% | 0.04% |
| May 29, 2024 | Bailey Gregory | Director | P | Common Stock | 1173 | $9.50 | 15,001.0000 | 7,351,000 | 8.48% | 0.02% |
| May 30, 2024 | Bailey Gregory | Director | P | Common Stock | 5205 | $9.50 | 20,206.0000 | 7,351,000 | 34.70% | 0.07% |
| May 28, 2024 | Bailey Gregory | Director | P | Common Stock | 9019 | $9.50 | 13,828.0000 | 7,351,000 | 187.54% | 0.12% |
| May 21, 2024 | Bailey Gregory | Director | P | Common Stock | 916 | $9.50 | 2,438.0000 | 7,351,000 | 60.18% | 0.01% |
| May 23, 2024 | Bailey Gregory | Director | P | Common Stock | 2371 | $9.50 | 4,809.0000 | 7,351,000 | 97.25% | 0.03% |
| May 17, 2024 | MINTZ STEVEN | Director | P | Common Stock | 554 | $8.50 | 6,341.0000 | 7,351,000 | 9.57% | 0.01% |
| May 20, 2024 | MINTZ STEVEN | Director | P | Common Stock | 195 | $9.48 | 6,536.0000 | 7,351,000 | 3.08% | 0.00% |
| May 21, 2024 | MINTZ STEVEN | Director | P | Common Stock | 6651 | $10.00 | 13,187.0000 | 7,351,000 | 101.76% | 0.09% |
| May 21, 2024 | MINTZ STEVEN | Director | P | Common Stock | 2500 | $9.75 | 15,687.0000 | 7,351,000 | 18.96% | 0.03% |
| May 20, 2024 | MINTZ STEVEN | Director | P | Common Stock | 1240 | $9.44 | 15,687.0000 | 7,351,000 | 8.58% | 0.02% |
| May 20, 2024 | MINTZ STEVEN | Director | P | Common Stock | 1240 | $9.42 | 15,687.0000 | 7,351,000 | 8.58% | 0.02% |
| May 21, 2024 | Bailey Gregory | Director | P | Common Stock | 1422 | $9.50 | 1,522.0000 | 7,351,000 | 1422.00% | 0.02% |
| May 20, 2024 | Bailey Gregory | Director | P | Common Stock | 100 | $9.00 | 100.0000 | 7,351,000 | 9999.99% | 0.00% |
| April 15, 2024 | GILL SIMBA | Director | A | Stock Option (right to buy) | 295300 | $0.00 | 295,300.0000 | 7,351,000 | 9999.99% | 4.02% |
| April 1, 2024 | Bailey Gregory | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 44,691.0000 | 7,351,000 | 852.70% | 0.54% |
| April 1, 2024 | MINTZ STEVEN | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 41,812.0000 | 7,351,000 | 2207.51% | 0.54% |
| April 1, 2024 | Marshall Richard Peter | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 7,351,000 | 9999.99% | 0.54% |
| April 1, 2024 | HARRIS J MILTON | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 110,332.0000 | 7,351,000 | 56.87% | 0.54% |
| April 1, 2024 | Gross Remy | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 157,219.0000 | 7,351,000 | 34.12% | 0.54% |